X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ALEMBIC LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ALEMBIC LTD PFIZER/
ALEMBIC LTD
 
P/E (TTM) x 33.2 55.3 60.0% View Chart
P/BV x 4.9 3.1 158.3% View Chart
Dividend Yield % 0.8 0.4 213.0%  

Financials

 PFIZER   ALEMBIC LTD
EQUITY SHARE DATA
    PFIZER
Mar-17
ALEMBIC LTD
Mar-16
PFIZER/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs2,05553 3,892.0%   
Low Rs1,65129 5,635.2%   
Sales per share (Unadj.) Rs429.84.7 9,106.2%  
Earnings per share (Unadj.) Rs73.68.8 839.0%  
Cash flow per share (Unadj.) Rs87.49.0 970.4%  
Dividends per share (Unadj.) Rs20.000.15 13,333.3%  
Dividend yield (eoy) %1.10.4 295.4%  
Book value per share (Unadj.) Rs528.727.7 1,906.9%  
Shares outstanding (eoy) m45.75267.03 17.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.38.7 49.6%   
Avg P/E ratio x25.24.7 538.0%  
P/CF ratio (eoy) x21.24.6 465.2%  
Price / Book Value ratio x3.51.5 236.7%  
Dividend payout %27.21.7 1,589.1%   
Avg Mkt Cap Rs m84,77710,962 773.4%   
No. of employees `0002.8NA-   
Total wages/salary Rs m3,039238 1,276.8%   
Avg. sales/employee Rs Th6,925.9NM-  
Avg. wages/employee Rs Th1,070.4NM-  
Avg. net profit/employee Rs Th1,186.3NM-  
INCOME DATA
Net Sales Rs m19,6631,260 1,560.2%  
Other income Rs m1,012264 383.5%   
Total revenues Rs m20,6741,524 1,356.5%   
Gross profit Rs m3,49183 4,216.5%  
Depreciation Rs m62961 1,024.9%   
Interest Rs m100 3,200.0%   
Profit before tax Rs m3,864285 1,356.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m1,304-32 -4,050.9%   
Tax Rs m1,8016 29,518.0%   
Profit after tax Rs m3,3682,343 143.8%  
Gross profit margin %17.86.6 270.3%  
Effective tax rate %46.62.1 2,176.4%   
Net profit margin %17.1185.9 9.2%  
BALANCE SHEET DATA
Current assets Rs m20,7891,689 1,231.0%   
Current liabilities Rs m7,870486 1,618.6%   
Net working cap to sales %65.795.4 68.9%  
Current ratio x2.63.5 76.1%  
Inventory Days Days60217 27.5%  
Debtors Days Days2281 27.7%  
Net fixed assets Rs m9,1751,624 565.0%   
Share capital Rs m458534 85.7%   
"Free" reserves Rs m23,7315,960 398.2%   
Net worth Rs m24,1897,404 326.7%   
Long term debt Rs m25104 24.0%   
Total assets Rs m32,7068,010 408.3%  
Interest coverage x403.5950.7 42.4%   
Debt to equity ratio x00 7.3%  
Sales to assets ratio x0.60.2 382.1%   
Return on assets %10.329.3 35.3%  
Return on equity %13.931.6 44.0%  
Return on capital %21.431.3 68.3%  
Exports to sales %02.9 0.0%   
Imports to sales %028.9 0.0%   
Exports (fob) Rs mNA37 0.0%   
Imports (cif) Rs mNA364 0.0%   
Fx inflow Rs m6337 169.5%   
Fx outflow Rs m4,067365 1,114.3%   
Net fx Rs m-4,004-328 1,221.3%   
CASH FLOW
From Operations Rs m3,288346 951.4%  
From Investments Rs m-2,496-48 5,244.3%  
From Financial Activity Rs m-826-301 274.4%  
Net Cashflow Rs m-35-3 1,153.3%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 4.9 9.7 50.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 26.1 90.8%  
Shareholders   85,207 54,701 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   FDC LTD.  UNICHEM LAB  WYETH LTD  STRIDES SHASUN LTD  WOCKHARDT LTD.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Energy Stocks Lose(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.4% while the Hang Seng is down 0.5%. The Shanghai Composite is trading up by 0.2%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jun 25, 2018 11:21 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS